Description
RADIOPHARMACEUTICALS
First action · last action
2014-10-01 · 2017-11-02
Transactions
3
First transaction's obligation
$627,829
Base + all options value (sum of deltas)
$246,889
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
VA26313D0231
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2014-10-01+$627,829= $627,829
- Mod P000012015-09-03-$277,833= $349,996
- Mod P000032017-11-02-$103,107= $246,889
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2014-10-01 | +$627,829 | $627,829 | RADIOPHARMACEUTICALS |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2015-09-03 | −$277,833 | $349,996 | RADIOPHARMACEUTICALS |
| Mod P00003· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2017-11-02 | −$103,107 | $246,889 | RADIOPHARMACEUTICALS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI NRMNYAAVZ767)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25522N0051 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $7,678 | FY2022 |
| 36C25521N0048 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $145,047 | FY2021 |
| 36C24120N0016 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS | $368,096 | FY2020 |
| 36C25519N0519 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $134,688 | FY2019 |
| 36C24419P0012 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $30,306 | FY2019 |
| 36C24819N0033 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $125,065 | FY2019 |
Other recipients under 6550 from 656-ST CLOUD VA MEDICAL CTR (00656) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C26318N0164 | CEPHEID | 656-ST CLOUD VA MEDICAL CTR (00656) | $7,037 | FY2018 |
| VA26317J1452 | POLYMEDCO CANCER DIAGNOSTIC PRODUCTS LLC | 656-ST CLOUD VA MEDICAL CTR (00656) | $37,051 | FY2018 |
| VA26317J1481 | ABBOTT LABORATORIES INC. | 656-ST CLOUD VA MEDICAL CTR (00656) | $49,134 | FY2018 |
| VA26317F1466 | GOVERNMENT SCIENTIFIC SOURCE INC | 656-ST CLOUD VA MEDICAL CTR (00656) | $26,195 | FY2018 |
| VA26317J1665 | ROCHE DIAGNOSTICS CORPORATION | 656-ST CLOUD VA MEDICAL CTR (00656) | $50,720 | FY2018 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26315J0005_3600_VA26313D0231_3600 · retrieved 2026-09-26.